Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Macrogen

Seegene Macrogen, who used to be popular, is now busy to appease the backlash from shareholders

Seegene Macrogen, who used to be popular, is now busy to appease the backlash from shareholders

MEDI:GATE NEWS Macrogen’s first cash dividend decision since its inception…  Efforts to enhance shareholder value

MEDI:GATE NEWS Macrogen’s first cash dividend decision since its inception… Efforts to enhance shareholder value

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en